1,721,494 research outputs found

    Mitosi e Citochinesi

    No full text

    Fase S e replicazione del DNA

    No full text

    Meiosi

    No full text

    Morte Cellulare Programmata

    No full text

    Introduzione al Ciclo Cellulare

    No full text

    The autophagosome and lysosome pathway in motoneuron diseases

    No full text
    The in­tra­cellular organelles auto­phagosomes and lysosomes are the essential components of a high capacity degradative pathway. Autophagosomes have two double layer mem­branes and are formed by engulfing damaged, misfolded and ag­gre­gated pro­teins or even organelles to be cleared from cells. Autophagosomes fuse with lysosomes, and the entire content of the newly formed auto­phago-lysosomes is digested by the lysosomal enzymes. The entire pro­cess is named auto­phagy, an essenzial component of the pro­tein quality control (PQC) system in cells. The PQC system also requires chaperones and the pro­teasome that work synergistically to auto­phagy degradative pathways. Autophagy is altered in motorneu­ronal dis­eases (MNDs), like Spinal bulbar muscular atrophy (SBMA) and Amyotrophic lateral sclerosis, in which spe­ci­fic mutant or aberrant misfolded pro­teins accu­mulate causing auto­phagic flux blockage, possibly leading to neu­ronal death. We found that a peculiar chaperone, the small heat shock pro­tein (HSP) B8, is able to revert the auto­phagy flux blockage by facilitating the auto­phagic removal of misfolded pro­teins pro­ne to ag­gre­gate in MNDs. HSPB8 is induced in re­sponse to several neu­ronal stresses such has pro­teotoxic and oxi­dative stresses. We found that HSPB8 is highly induced in the two main targets of misfolded pro­tein toxicity in tg mice models of SBMA and ALS, the motorneu­rons and the muscle. HSPB8 acts in conjunction with BAG3 to bind the HSC70-CHIP mediator of degradation, and the pharma­cological or ge­net­ic induction of HSPB8 ex­pression is pro­tective in MNDs, while its silencing has opposite effects. We also showed that HSPB8 pro­tects from a misfolded pro­tein induced aberrant phenotype in fly models of ALS. By in­creasing the HSPB8-mediated selective targeting of misfolded pro­teins to auto­phagy neu­rons and muscle re­duce their pro­teasome-mediated clearance limiting its possible overwhelming. There­fore, pharma­cological appro­ached which po­tentiate the HSPB8-BAG3 auto­phagic pathway could con­tri­bute to main­tain a correct pro­teostasis in motorneu­ron and muscle cells and might have thera­peutic implication in MNDs
    corecore